Investigator-Focused Award (Parent R35)
Agency
National Institutes of Health
Posted
Jul 30, 2026
Due Date
Oct 4, 2027
Description
<p style="margin-left:0in;">The National Institutes of Health intends to publish a Parent R35 "Investigator-Focused Award" Notice of Funding Opportunity (NOFO) to fund research programs for investigators at all career stages, including Early Stage Investigators (ESIs). The Parent R35 Investigator-Focused Award is intended to provide support for an investigator's program of research within the mission of the awarding Institute or Center (IC) rather than support for a pre-defined project with specific aims. </p><p style="margin-left:0in;">The R35 is typically expected to be an investigator's primary (or only) source of research funding from the awarding IC. </p><p style="margin-left:0in;">An R35 award gives investigators funding stability and scientific freedom. With R35 support, researchers can pursue ambitious and innovative studies without the pressure of constantly seeking new funding streams. Key benefits include: </p><ul style="list-style-type:disc;"><li data-list-item-id="e2a51b9b2f802d0997d7f1ec9835f107a">Providing flexibility to follow the science as it evolves within the awarding IC's mission.</li><li data-list-item-id="e1a6c6c293717938bfc7dec65a6fd0f8b">Providing stability to take on important, challenging research questions.</li><li data-list-item-id="e479d5de8c44782af184b3cabf85319e2">Allowing recipients to devote sufficient time to research, mentoring, and scientific service, and less time to grant administration.</li><li data-list-item-id="e63511b680a2c6718ebf31dc7830c28c5">Providing a high potential for scientific breakthroughs by enabling investigators to think broadly and pursue promising opportunities. </li></ul>
AI Summary
Agency: National Institutes of Health
Details
- Notice ID
- 363391
- Solicitation Number
- PAR-28-037
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health